D. Kyriakou et al., SYSTEMIC MASTOCYTOSIS - A RARE CAUSE OF NONCIRRHOTIC PORTAL-HYPERTENSION SIMULATING AUTOIMMUNE CHOLANGITIS - REPORT OF 4 CASES, The American journal of gastroenterology, 93(1), 1998, pp. 106-108
Four patients with systemic mastocytosis, two men and two women, are p
resented. Three of them (patients 1, 2, and 4) developed portal hypert
ension and ascites without histological evidence of cirrhosis in liver
biopsy, The remaining patient (patient 3) had severe bone lesions wit
h multiple vertebral fractures, None of the patients had skin or lymph
node involvement, Two patients (patients 1 and 2) died 12 and 9 month
s after diagnosis with acute nonlymphocytic leukemia and overt mastocy
tic leukemia, respectively, while time other true (patients 3 and 4) a
re alive 58 and 14 months after diagnosis, Treatment with hydroxyurea
or cytosine arabinoside had not any beneficial effect in two patients,
while a substantial amelioration of back pain had been obtained by lo
cal irradiation and recombinant human interferon-alpha-2b administrati
on in one patient (patient 3), All patients had laboratory findings co
mpatible with autoimmune cholangitis, We concluded that systemic masto
cytosis is a rare cause of noncirrhotic portal hypertention often simu
lating autoimmune cholangitis and leading tea the erroneous diagnosis
of liver cirrhosis. Diagnosis is based on the presence of mast cells i
n Giemsa-stained lives histological sections, and it may be confirmed
by immunohistochemical detection of tryptase in the cytoplasm of these
abnormally proliferating cells, (C) 1998 by Am. Coll. of Gastroentero
logy.